Anthony Hunt, Chief Executive Officer at REPLIGEN CORP (RGEN), sold 32,270 shares at $187.60 ($6.0M) on 2020-11-19, disclosed to the SEC on 2020-11-23.
Open-market sale of $6.0M RGEN by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $184.69 | 5,447 | $1.0M | 16.8% |
| 2 | $184.69 | 5,447 | $1.0M | 16.8% |
| 3 | $185.67 | 6,823 | $1.3M | 21.2% |
| 4 | $185.67 | 6,823 | $1.3M | 21.2% |
| 5 | $186.50 | 6,300 | $1.2M | 19.6% |
| 6 | $187.60 | 1,430 |
| $268K |
| 4.5% |
| Total | $185.59 avg | 32,270 | $6.0M | 100% |
| Filing → |
| RGEN | SELL | 2025-09-11 | $7.0M | — | Filing → |
| RGEN | SELL | 2025-05-16 | $6.5M | — | Filing → |
| RGEN | SELL | 2025-03-19 | $8.1M | — | Filing → |